1-4 of 4
Chong-Yang Ding
Close
Sort by
Journal Articles

Orelabrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (OFCG) for First-Line Treatment of Chronic Lymphocytic Leukemia: A Multicenter, Investigator-Initiated Study (cwCLL-001 Study)

Huayuan Zhu, Yi Miao, Yi Xia, Shuchao Qin, Wei Wu, Tonglu Qiu, Chong-Yang Ding, Hairong Qiu, Chun Qiao, Yujie Wu, Fei Li, Wei Xu, Jianyong Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 4642.
https://doi.org/10.1182/blood-2023-188925
Published: 2023
Journal Articles

Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab As the Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia: A Single-Center Real World Study

Huayuan Zhu, Hui Shen, Yilian Yang, Chong-Yang Ding, MD, Yeqin Sha, Hongling Mi, Jingyan Qiu, Ruize Chen, Yujie Wu, Chun Qiao, Li Wang, MD, Lei Fan, MD PhD, Wei Xu, MD PhD, Jianyong Li, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-141747
Published: 2020
Journal Articles

Prognostic Value of Baseline and Interim Total Metabolic Tumour Volume and Total Lesion Glycolysis Measured on 18 f-FDG PET/CT in Patients with Follicular Lymphoma

Jin-Hua Liang, MD, Wei Xu, MDPhD, Chong-Yang Ding, MD, Li Wang, MD, Lei Fan, MD PhD, Jian-Yong Li, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4047.
https://doi.org/10.1182/blood.V130.Suppl_1.4047.4047
Published: 2017
Journal Articles

The Prognostic Value of Whole-Body Suvmax of Nodal and Extranodal Lesions Detected By 18F-FDG PET-CT in Patients with Extranodal NK/T-Cell Lymphoma

Jin-Hua Liang, Chong-Yang Ding, Li Wang, Lei Fan, MD, PhD, Tian-Nv Li, Jian-Yong Li, MD PhD, Wei Xu
Journal: Blood
Blood (2015) 126 (23): 3918.
https://doi.org/10.1182/blood.V126.23.3918.3918
Published: 2015